nanoparticle therapies
What I like so much about this idea is that it is so much less myopic, and seems more likely to help the 70% who are not HER2 positive as well as those of us who are.... resources are limited and therapies that are likely to be effective on more or all groups deserve priority in funding.
A.A.
|